Related Experiment Video
Updated: Feb 12, 2026

Author Spotlight: A Computational Pipeline for Analyzing Chimeric Noncoding RNA-Target RNA Interactions in High-Throughput Sequencing Data
Published on: December 1, 2023
Genome Sequencing and RNA-Motif Analysis Reveal Novel Damaging Noncoding Mutations in Human Tumors
Babita Singh1, Juan L Trincado1, P J Tatlow2
1Department of Experimental and Health Sciences, Pompeu Fabra University (UPF), Barcelona, Spain.
Abstract:
A major challenge in cancer research is to determine the biological and clinical significance of somatic mutations in noncoding regions. This has been studied in terms of recurrence, functional impact, and association to individual regulatory sites, but the combinatorial contribution of mutations to common RNA regulatory motifs has not been explored. Therefore, we developed a new method, MIRA (mutation identification for RNA alterations), to perform an unbiased and comprehensive study of significantly mutated regions (SMR) affecting binding sites for RNA-binding proteins (RBP) in cancer. Extracting signals related to RNA-related selection processes and using RNA sequencing (RNA-seq) data from the same specimens, we identified alterations in RNA expression and splicing linked to mutations on RBP binding sites. We found SRSF10 and MBNL1 motifs in introns, HNRPLL motifs at 5' UTRs, as well as 5' and 3' splice-site motifs, among others, with specific mutational patterns that disrupt the motif and impact RNA processing. MIRA facilitates the integrative analysis of multiple genome sites that operate collectively through common RBPs and aids in the interpretation of noncoding variants in cancer. MIRA is available at https://github.com/comprna/miraImplications: The study of recurrent cancer mutations on potential RBP binding sites reveals new alterations in introns, untranslated regions, and long noncoding RNAs that impact RNA processing and provide a new layer of insight that can aid in the interpretation of noncoding variants in cancer genomes. Mol Cancer Res; 16(7); 1112-24. ©2018 AACR.
Insights
A new method, MIRA, analyzes cancer mutations in noncoding RNA regions. It identifies how mutations in RNA-binding protein motifs impact RNA processing, offering insights into cancer genome variants.
Area of Science:
- Genomics
- Cancer Research
- RNA Biology
Background:
- Determining the significance of somatic mutations in noncoding cancer regions is challenging.
- Previous studies focused on individual regulatory sites, not combinatorial effects on RNA motifs.
- The role of mutations in common RNA regulatory motifs in cancer remains underexplored.
Purpose of the Study:
- To develop a method for unbiased, comprehensive study of significantly mutated regions affecting RNA-binding protein (RBP) binding sites in cancer.
- To investigate the combinatorial contribution of mutations to common RNA regulatory motifs.
- To identify alterations in RNA expression and splicing linked to mutations on RBP binding sites.
Main Methods:
- Developed MIRA (mutation identification for RNA alterations) for analyzing noncoding mutations.
- Utilized RNA sequencing (RNA-seq) data alongside mutation data.
- Identified significantly mutated regions (SMRs) impacting RBP binding sites.
Main Results:
- Identified SRSF10, MBNL1, and HNRPLL motifs in introns and UTRs with specific mutational patterns.
- Found mutations disrupting motifs and impacting RNA processing, including splicing.
- Linked mutations in RBP binding sites to altered RNA expression and splicing.
Conclusions:
- MIRA facilitates integrative analysis of multiple genome sites acting through common RBPs.
- The study aids in interpreting noncoding variants in cancer genomes.
- Identified novel alterations in introns, UTRs, and long noncoding RNAs affecting RNA processing.
Related Concept Videos
Mutations
Viruses with RNA Genomes
Viral Mutations
Genomics
Genome Size and the Evolution of New Genes
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...

